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Abstract 
Rationale: Among the biothiols-related diseases, sepsis is defined as life-threatening organ 
dysfunction caused by a dysregulated host response to infection and can result in severe oxidative 
stress and damage to multiple organs. In this study, we aimed to develop a fluorescence 
chemosensor that can both detect GSH and further predict sepsis. 
Methods: In this study, two new naphthalene dialdehyde compounds containing different functional 
groups were synthesized, and the sensing abilities of these compounds towards biothiols and its 
applications for prediction of sepsis were investigated.  
Results: Our study revealed that the newly developed probe 6-methoxynaphthalene-2, 
3-dicarbaldehyde (MNDA) has two-photon is capable of detecting GSH in live cells with two-photon 
microscopy (TPM) under the excitation at a wavelength of 900 nm. Furthermore, two GSH 
detection probes naphthalene-2,3-dicarboxaldehyde (NDA) and 6-fluoronaphthalene-2,3- 
dicarbaldehyde (FNDA) not only can detect GSH in living cells, but also showed clinical significance 
for the diagnosis and prediction of mortality in patients with sepsis.  
Conclusions: These results open up a promising direction for further medical diagnostic 
techniques. 
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Introduction 
Biothiols, including glutathione (GSH), cysteine 
(Cys) and homocysteine (Hcy), play important roles 
in biological systems and physiological processes. 
Abnormal levels of GSH are associated with many 
diseases, such as sepsis, liver damage, cancer, AIDS, 
osteoporosis, and Alzheimer’s, heart, inflammatory 
bowel, and cardiovascular diseases.[1-5] Cys 
deficiency is involved in many syndromes, including 
 
Ivyspring  
International Publisher 
 Theranostics 2018, Vol. 8, Issue 1 
 
 
http://www.thno.org 
1412 
slow growth in children, hair depigmentation, 
oedema, lethargy, liver damage, loss of muscle and 
fat, skin lesions, and weakness.[6] A high level of Hcy 
in the blood (hyperhomocysteinaemia) makes a 
person more prone to endothelial cell injury, which 
leads to inflammation in the blood vessels and results 
in ischaemic injury.[7] Therefore, the detection of 
biothiol levels in the human biological system may 
help in the diagnosis of related diseases. Among the 
biothiols-related diseases, sepsis is defined as 
life-threatening organ dysfunction caused by a 
dysregulated host response to infection [8, 9] and can 
result in severe oxidative stress and damage to 
multiple organs. Patients with sepsis have low plasma 
GSH peroxidase activity and low GSH levels.[10-12] 
Although redox therapy in sepsis has rarely been 
successful in human clinical trials[13], the 
measurement of GSH levels has clinical significance. 
Recently, fluorescent probes have been regarded as 
powerful tools for molecular recognition and 
imaging. Over the past decade, substantial effort has 
been devoted to develop a highly selective and 
sensitive fluorescent probe for GSH detection that 
exhibits good performance in live cell and tissue 
imaging.[14-39] Very recently, Wang’s group 
developed a series of GSH reversible probes for 
real-time imaging of intracellular GSH.[40-43] Despite 
the great progress in biothiols detection, a 
fluorescence chemosensor that can both detect GSH 
and further predict sepsis has not yet been developed. 
Naphthalene-2, 3-dicarboxaldehyde (NDA) was 
reported as a fluorescent probe for GSH detection 
over 20 years ago[44]; however, the sensing 
mechanism for three biothiols has not been fully 
confirmed due to the complicated structure of the 
product that has never been isolated. We envisioned 
that GSH and Hcy/Cys react with an o-dialdehyde 
group in different modes, which would exhibit 
different fluorescence signal responses; by 
introducing different functional groups on a 
naphthalene ring (i.e., -H, -OCH3 and -F), the probes 
may display different sensing abilities towards 
biothiols. In this paper, we successfully isolated the 
reaction product of NDA with GSH and further 
confirmed its structure by NMR and HPLC-Mass. In 
addition, we firstly found that the newly developed 
probe MNDA (6-methoxynaphthalene-2, 
3-dicarbaldehyde) having an electron-donating group 
is capable of detecting GSH in live cells with TPM. 
Last but not least, we revealed that two GSH detection 
probes (NDA and FNDA) showed clinical significance 
for the diagnosis and prediction of mortality in 
patients with sepsis. 
Results and Discussion 
Synthesis of NDA derivatives 
The synthetic methods are detailed in Scheme 1 
and Supplementary Material. We successfully 
obtained the new target compounds MNDA and 
FNDA by using substituted benzaldehyde as the 
starting material. Substituted benzaldehyde was 
subjected to bromination, protection with an aldehyde 
group by using ethylene glycol to create dioxolane 
derivatives, the introduction of a new aldehyde group 
by using n-butyllithium/N, N-dimethylformamide 
(DMF) as reactants, and de-protection to obtain the 
key intermediate, a substituted phthalaldehyde. Then, 
we devised an iterative strategy to construct 
substituent naphthalene dialdehyde compounds via 
tandem Wittig olefination and intra-molecular 
Knoevenagel condensation according to a previous 
reference [45]. All of the target probes were confirmed 
via 1HNMR, 13CNMR and HRMS. 
UV and fluorescence properties of GSH probes 
After obtaining the above probes, we 
investigated the sensing abilities of the probes for 
biothiols. NDA, MNDA and FNDA were employed to 
detect amino acids containing thiol groups. 
Ultraviolet/visible (UV/Vis) absorption spectroscopy 
revealed that the addition of 100 µM GSH to the 
probes (10 µM) in 4-(2-hydroxyethyl)-1-pipe-
razineethanesulfonic acid (HEPES) buffer increased 
the absorbance at ~450 nm, whereas other amino acids 
containing thiol groups did not lead to obvious 
changes at the same wavelength. These changes 
indicated that NDA, MNDA and FNDA could detect 
GSH with high selectivity. For Hcy, only MNDA led 
to a distinct absorbance change at ~315 nm and ~350 
nm, suggesting that this probe can also sense Hcy. For 
Cys, no obvious change was observed using these 
three probes (Figures S1-S3). 
Further assessment of the fluorescence responses 
of NDA (ɸ = 0.0032, Figure S4), MNDA (ɸ = 0.0035, 
Figure 2a-b) and FNDA (ɸ = 0.0036, Figure S4) to GSH 
was conducted with excitation at 450 nm. After the 
addition of 100 µM GSH to the probes (10 µM) in 
HEPES buffer, fluorescence enhancement was 
observed at an emission wavelength of 531 nm 
(ɸNDA+GSH = 0.32, ɸMNDA+GSH = 0.28, ɸFNDA+GSH = 0.13), 
whereas other amino acids (including Hcy, Cys, Ala, 
DTT, Gln, Gly, His, Lys, Met, Pha and Ser) caused no 
increase in the fluorescence at the same excitation 
wavelength. Considering the existence of reactive 
oxygen species (ROS) in the cell and serum, we 
further checked the probes’ responses to ROS 
including 10 equivalences of H2O2, ONOO- and OCl-. 
The results indicate that those ROS cannot cause any 
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fluorescence increase after reaction with NDA (Figure 
S22a), MNDA (Figure S22b) or FNDA (Figure S22c). A 
time-dependence study showed that the fluorescence 
intensity at 531 nm approached a maximum within 30 
min (Figure S5). The pseudo-first-order rate constant 
(kobs) of the reaction between the probes and GSH 
were calculated as 1.4 × 10-3 s-1 (NDA), 1.6 × 10-3 s-1 
(MNDA), and 1.5 × 10-3 s-1 (FNDA), respectively. 
Subsequently, a concentration titration was 
performed via the addition of increasing 
concentrations of GSH, and the fluorescence intensity 
gradually increased at 531 nm. The intensity reached a 
maximum after the addition of 100 µM GSH. For 
NDA, a standard curve with a good linear 
relationship was obtained (Figure S6a), and the 
detection limit was calculated to be 6.4 ×10−8 M. For 
MNDA, the detection limit was 6.8 ×10−8 M (Figure 
S6b), and for FNDA the limit was 1.3 ×10−7 M (Figure 
S6c; CDL = 3 Sb/k). 
The sensing abilities of these three probes for 
Hcy and Cys were also investigated (Figure 2c). We 
found that only MNDA (ɸ=0.014, 10 µM) led to 
obvious fluorescence enhancement after the addition 
of 100 µM Hcy (excitation at 350 nm) in HEPES buffer 
(ɸMNDA+Hcy=0.39, Figure S7a). Thus, the presence of an 
electron-donating group on the naphthalene ring 
compared to an electron-withdrawing group 
increases the sensitivity for Hcy. Other amino acids 
(including GSH, Cys, Ala, DTT, Gln, Gly, His, Lys, 
Met, Pha and Ser) did not lead to an obvious increase 
in the fluorescence at the same excitation wavelength. 
The time dependence of 100 µM Hcy with 10 µM 
MNDA in HEPES buffer was also recorded, and the 
fluorescence intensity approached a maximum within 
30 min (Figure S7b). The pseudo-first-order rate 
constant (kobs) of the reaction between probe MNDA 
and Hcy was calculated as 1.8 × 10-3 s-1. For MNDA, a 
standard curve of Hcy with a good linear relationship 
in the 0−10 µM range was obtained (Figure S6d), and 
the detection limit was determined to be 6.3 ×10−8 M 
(CDL = 3 Sb/m). Cys also can lead to fluorescence 
enhancement in the same signal channel as Hcy; 
however, the kinetic study indicated that the reaction 
rate of Cys with MNDA is much slower (kobs= 4.6 S-1). 
For NDA and FNDA, little fluorescence enhancement 
was observed after addition of Hcy (Figure 2d). 
Because Hcy and GSH co-exist in cells, we further 
performed an experiment reacting MNDA with 100 
μM Hcy in the presence of 2 mM GSH (see Figure 
S23a: the fluorescence intensity saturated at 1 mM 
GSH and decreased from 2 mM GSH). For the 
quantification of GSH, the GSH concentration is better 
no more than 2 mM. When excited at 450 nm, the 
fluorescence intensity was stable at maximum in the 
green channel, but when excited at 350 nm, decreased 
intensity was observed in the blue channel (Figure 
S23b). Additionally, all three probes showed good 
stability over pH 3 to 10: for NDA, the fluorescence 
intensity reached the maximum after addition of 10 
equivalences GSH in pH 10, while for the newly 
developed GSH probes MNDA and FNDA, the 
maximum fluorescence intensity was stable in the 
range pH 7-10 after addition of 10 equivalences GSH 
(Figure S18). 
 
 
Figure 1. Simultaneous sensing of biothiols based on reactions with dialdehyde 
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Scheme 1 Synthetic route of NDA derivatives. Reagents and conditions: (a) ethylene glycol, p-toluenesulfonic acid, toluene, reflux; (b) n-BuLi/DMF, THF, -78 oC, N2; 
(c) FeCl3.6H2O, acetone or 10% HCl, r.t; (d) PEt3, dimethylmaleate, DBU, CH2Cl2; (e) diisobutylaluminium hydride solution, -50 oC; (f) DMSO, (COCl)2, -78 oC, N2. 
 
Figure 2. (a) Fluorescence responses of the newly developed probe MNDA (10 µM) to various amino acids in the green channel (including GSH, Hcy, Cys, Ala, DTT, 
Gln, Gly, His, Lys, Met, Pha and Ser, 100 µM each; excitation: 450 nm, slit widths: 3 nm, 3 nm). (b) Gradient titrations of MNDA with GSH in HEPES buffer solution. 
(c) Fluorescence responses of MNDA (10 µM) to various amino acids in the blue channel (including GSH, Hcy, Cys, Ala, DTT, Gln, Gly, His, Lys, Met, Pha and Ser, 
100 µM each; excitation: 350 nm, slit widths: 1.5 nm, 3 nm); (d) Comparison of the sensing abilities of probes toward Hcy (excitation: 350 nm, slit widths: 1.5 nm, 3 
nm). 
 
Sensing mechanism of NDA and its derivatives 
The reactions of GSH with the three probes 
mentioned above were monitored by liquid 
chromatography-mass spectrometry (LC-MS) (Figure 
S8). We found that the fluorescent derivatives suffer 
from on-column decomposition or rapid hydrolysis in 
the relatively aqueous buffer or the mobile phase in 
HPLC (Figure S12). The mass spectra (Figure S8) 
showed peaks at m/z of 473.0 (NDA+GSH), 502.9 
(MNDA+GSH), and 492.0 (FNDA+GSH). 
Furthermore, we successfully isolated the product of 
the reaction of GSH with NDA, and its structure was 
confirmed by 1D and 2D nuclear magnetic resonance 
(NMR) (Figure S9). The 1H NMR spectra displayed six 
aromatic protons [H 8.37, 8.16, 8.12, 8.06, 7.65, and 
7.59] and downfield protons [H 4.84, 4.64, 4.42, and 
3.72]. Analysing the 2D NMR spectroscopic data, 
including those collected via correlation spectroscopy 
(COSY), heteronuclear single quantum coherence 
(HSQC), and heteronuclear multiple bond correlation 
(HMBC), indicated the presence of naphthalene 
[C-12a (C 136.8), H-13 (H 8.12, s)/C-13 (C 122.0), 
C-13a (C 134.7), H-14 (H 8.06, d, J = 8.0 Hz)/C-14 (C 
127.9), H-15 (H 7.65, dd, J = 8.0, 8.0 Hz)/C-15 (C 
127.6), H-16 (H 7.59, dd, J = 8.0, 8.0 Hz)/C-16 (C 
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126.2), H-17 (H 8.16, d, J = 8.0 Hz)/C-17 (C 129.3), 
C-17a (C 132.3), H-18 (H 8.37, s)/C-18 (C 123.0), C-18a 
(C 130.0)] and GSH [C-1 (C 172.0), H-2 (H 4.84, dd, J = 
11.0, 4.0 Hz)/C-2 (C 53.3), H-3 (H 2.12, m)/C-3 (C 
24.8), H-4 (H 2.35, m)/C-4 (C 24.8), C-5 (C 171.2), H-6 
(H 4.42, m,)/C-6 (C 54.7), C-7 (C 170.1), H-8 (H 3.72, d, 
J = 5.0 Hz)/C-8 (C 40.7), C-9 (C 170.8), H-10 (H 2.75, 
2.65, d, J = 4.8 Hz)/C-10 (C 26.1)] moieties. Further 
interpretation of the HMBC spectroscopic data 
confirmed the chemical structure of the product. The 
observation of three HMBC bond correlations from an 
aromatic singlet H-18 (H 8.37, s) to C-11 (C 167.8) and 
from methylene proton H-12 (H 4.64, d, J = 11.0 Hz) to 
C-13 (C 122.0) allowed the attachment of C-18/C-11 
and C12a/C-12, respectively, permitting the 
2,3-dihydro-1H-benzo[f]isoindol-1-one moiety. The 
connectivity between this fragment and the GSH 
moiety was determined by analysing the HMBC 
spectroscopic data. The long-range HMBC 
correlations from H-2 to C-11 and C-12 (C 46.6) and 
from H-12 to C-2 elucidated the C-2-N attachment, 
completing the assignment of the product, as shown 
in Figure S10. The peak emission wavelength of the 
product is in agreement with previously collected 
fluorescence data (Figure S11). The UV absorption 
spectra, however, do not have any absorbance at ~450 
nm, which is different from Figures S1-S3 due to the 
decomposition as mentioned above. The mechanism 
underlying the interaction of Hcy and Cys with the 
probes is a little bit different from that of GSH. The 
amino group of Hcy/Cys firstly reacts with a 
dialdehyde group, producing an imine derivative, 
and then the imine bond undergoes nucleophilic 
attack by the thiol group of Hcy/Cys to form a stable 
six- or five-membered ring. Subsequently, the amino 
group on the six- or five-membered ring reacts with 
another aldehyde group in the ortho-position to form 
the final product (Figure S12). The HPLC-MS results 
support our proposal (Figure S8). For Hcy, the mass 
spectra showed peaks at m/z 283.2 (NDA+Hcy), 313.4 
(MNDA+Hcy), and 302.1 (FNDA+Hcy). For Cys, 
peaks at m/z 269.6 (NDA+Cys), 299.2 (MNDA+Cys), 
and 288.1 (FNDA+Cys) were observed.  
One photon imaging of probes with GSH 
Subsequently, the capabilities of the probes to 
selectively sense intracellular thiols were established. 
NDA (Figure S13a), MNDA (Figure 3a) and FNDA 
(Figure S15a, 3 µM) were incubated for 30 min at 37 
°C, and strong green fluorescence was observed in 
HeLa cells by confocal fluorescence microscopy. This 
result shows that these probes have excellent cell 
permeability. After treatment with 
N-methylmaleimide (NMM, 1 mM), which is 
commonly employed as a thiol-blocking reagent, for 
30 min and incubation with NDA (Figure S13b), 
MNDA (Figure 3b) and FNDA (Figure S15b, 3 µM), 
the fluorescence was markedly quenched. Further 
addition of GSH-monoethyl ester (MEE) resulted in 
strong fluorescence (Figure S13c, 3e and S15c), 
demonstrating that these three probes can efficiently 
monitor intracellular GSH. Very interestingly, probe 
MNDA can also effectively image Hcy in different 
signal channels (blue) in HeLa cell (Figure 3d) while 
Cys only leads to tiny fluorescence enhancement in 
the same channel (Figure 3c).  
 
 
Figure 3. Fluorescence imaging in cells. HeLa cells were pre-incubated with the following agents: (a) no treatment; (b) 1 mM NMM for 30 min; (c) 1 mM NMM for 
30 min and 300 μM Cys for 30 min; (d) 1 mM NMM for 30 min and 300 µM Hcy for 30 min; (e) 1 mM NMM for 30 min and 1 mM GSH-MEE for 60 min. Cells were 
then washed with Dulbecco's phosphate-buffered saline (DPBS) and incubated with 10 µM MNDA for 30 min. After washing with DPBS, fluorescence images were 
acquired by confocal microscopy. Blue: ex. 405 nm/em. 430–455 nm, green: ex. 473 nm/em. 490-540 nm. Scale bar: 10 µm. 
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The detection of changes in intracellular GSH 
levels resulting from drug treatment was successfully 
established using NDA (Figures S14), MNDA (Figures 
4) and FNDA (Figures S16). HeLa cells were 
incubated with 100 µM buthioninesulfoximine (BSO), 
which is an inhibitor of the 
γ-glutamylcysteinesynthetase enzyme for GSH 
synthesis, and weak fluorescence was observed after 
treatment with the probe (3 µM). The addition of 1 
mM GSH-MEE led to significant fluorescence 
enhancement in the cells. Cisplatin, which is an 
anticancer drug and a known GSH-oxidizing agent, 
was employed to test reactivity of the probe to redox 
status of glutathione in living cells. As expected, the 
addition of cisplatin (50 µM) caused fluorescence 
quenching after incubation with the probes (3 µM), 
whereas further treatment with N-acetyl-l-cysteine 
(NAC), which can be converted to GSH in cells, 
significantly increased the green fluorescence. 
Moreover, a standard 3-(4, 5-dimethylthiazol-2-yl)-2, 
5-diphenyltetrazolium bromide (MTT) assay using 
HeLa cells was performed with different 
concentrations of probes (MNDA and FNDA, see 
figure S17). The results showed that even after 
incubation with 10 μM probes for 24 h, >90% of the 
HeLa cells survived, indicating that the probes cause 
low cytotoxicity in living cells. These data 
demonstrate that NDA, MNDA and FNDA are ideal 
tools for the intracellular detection of GSH in living 
cells. Furthermore, we investigated the binding ability 
of our probes with proteins, many commercial GSH 
detection kits were removed protein and enzyme 
which may interfere GSH detection. The total cell was 
harvested by hypotonic buffer; and the majority of 
protein and non protein parts were isolated using the 
Amicon Ultra-15 centrtifugal filter devices which can 
separate cell lysis solution molecular weight over 3000 
Dalton; and the majority of proteins have 3000 Dalton 
or above. According to Figure S25, both of protein and 
non protein parts can cause fluorescence 
enhancement in the present of three probes. 
Therefore, our probes could also bind with the cell 
proteins.  
Two photon imaging of MDNA with GSH 
The successful imaging of intracellular GSH in 
one photon mode motivated us to investigate two 
photon (TP) properties of the above probes. We found 
that the TP action spectra of MNDA and the reaction 
product between MNDA and GSH in HEPES buffer 
solution showed cross section (Φδ) values of 1.1 and 
0.15 GM at 920 nm, respectively (Figure S21). This 
result indicates a 10-fold increase in the two-photon 
excited fluorescence (TPEF) intensity. In comparison, 
for NDA and FNDA, no TP property was observed. 
Furthermore, we tested the ability of MNDA to detect 
thiols in live cells by using TPM. The TPM image of 
the MNDA-labelled HeLa cells was bright, 
presumably because of their easy loading, convenient 
rate of thiol-induced decomposition, and the 
considerable Φδ value of the reaction product (Figure 
5a). The TPEF intensity decreased dramatically when 
the cells were pre-incubated with NMM for 30 min 
(Figure 5b), and increased significantly upon addition 
of GSH-MEE (Figure 5c). Hence, MNDA is capable of 
detecting GSH in live cells with TPM. 
We then investigated the utility of MNDA in live 
tissue imaging. The TPM image reveals the CA1 and 
CA3 regions as well as the dentate gyrus (DG; Figure 
6a). The TPM image of a part of a fresh rat 
hippocampal slice incubated with 50 μM MNDA for 
50 min shows that thiols are abundant in the CA1 and 
DG regions at a 90-180 μm depth. The image at a 
higher magnification clearly reveals the thiol 
distribution in the CA1 region at a 100 μm depth 
(Figure 6b). Further, the TPEF intensity decreased 
dramatically when the tissue slice was pretreated with 
NMM (Figure 6c). The control image without staining 
of the probe showed no TPEF, indicating the 
negligible interference by autofluorescence (Figure 
S24). These results demonstrate that MNDA is useful 
for detection of thiols at a 90-180 μm depth in live 
tissues using TPM. 
 
 
 
 
 
Figure 4. Changes in the intracellular GSH level after drug treatment. HeLa 
cells were incubated with (a) no treatment; (b) 100 µM BSO for 6 h; (c) 100 µM 
BSO with 1 mM GSH-MEE for 6 h; (d) 50 µM cisplatin for 6 h; (e) 50 µM cisplatin 
with 2 mM NAC for 6 h. Cells were then stained with 3 µM MNDA for 30 min 
and imaged withex. 473 nm/em. 490-590 nm. Scale bar: 10 µm. 
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Figure 5. TPM images of 10 µM MNDA-labelled HeLa cells. HeLa cells were 
pre-incubated with the following agents: (a) no treatment; (b) 1 mM NMM for 
30 min; (c) 1 mM NMM for 30 min and 1 mM GSH-MEE for 60 min. Cells were 
then washed with Dulbecco's phosphate-buffered saline (DPBS) and incubated 
with 10 µM MNDA for 30 min. TPM images were excited at900 nm and 
acquired at 400–600 nm. Scale bar: 10 µm. 
 
Application of GSH probes in serum 
As is well-known, GSH not only exist in the cell 
but also in serum that is closely associated with 
several physiological diseases including sepsis. Thus, 
we investigated whether the probes could detect the 
alteration of GSH levels in the plasma of patients with 
sepsis. We first examined the baseline characteristics 
of all of the participants, including both healthy 
volunteers and sepsis patients. Among the 112 
participants, there were 15 (male = 9, female = 6) 
healthy controls and 97 (male = 70, female = 27) sepsis 
patients (Figure 7). The values of inflammatory 
cytokines, including interleukin (IL)-18, IL-6 and 
IP-10, were significantly higher in sepsis patients than 
in healthy controls. Interestingly, the fluorescence 
intensities of NDA and FNDA were decreased in 
sepsis patients compared with those in healthy 
controls (Table S1). These results indicate that two 
probes, NDA and FNDA, can be used to monitor the 
decreased plasma GSH concentrations caused by 
sepsis. 
To determine whether the fluorescence 
intensities obtained using NDA and FNDA can 
predict the mortality rate in sepsis patients, we 
divided sepsis patients into two groups: survivors 
after 28 days of hospitalization (i.e., 28-d survivors) 
and non-survivors after 28 days of hospitalization 
(i.e., 28-d non-survivors) (Table S2). The fluorescence 
intensities of NDA and FNDA of the 28-d 
non-survivors were significantly lower than those of 
the 28-d survivors (Table S2). The APACHE II and 
SOFA scores were designed to measure the severity of 
disease in adult patients admitted to intensive care 
units (ICUs).[46-48] Specifically, an increase in the 
SOFA score predicts an increased risk of morbidity 
and mortality due to sepsis.[49, 50] In accordance with 
the lower fluorescence intensities obtained using 
NDA and FNDA in the 28-d non-survivors than in the 
28-d survivors, the APACHE II and SOFA scores were 
higher in the 28-d non-survivors than in the 28-d 
survivors (Table S2).  
 
Figure 6. (a) Accumulated TPM images of a fresh rat hippocampal slice stained 
with 50 μM MNDA at a depth of 90-180μm with a magnification of 10×. Scale 
bar: 300 μm. (b) TPM image in the CA1 region (red box) at a depth of ~100 μm 
with amagnification of100×. Scale bar: 30 μm. (c) TPM image of (b) pretreated 
with NMM (200 μM) before labelling with 20 μM MNDA. The TPEF were 
collected at 400-600 nm upon excitation at 900 nm with fs pulse. 
 
Figure 7. Study diagram of the GSH probe for sepsis. 
 
When comparing the fluorescence intensities 
from NDA and FNDA in the three groups (healthy 
controls, 28-d survivors, and 28-d non-survivors), the 
levels gradually decreased as the sepsis conditions 
increased in severity (Figure 8). HPLC analysis 
supports these results and confirmed the product in 
the serum under the same conditions (Figure S 20). 
When comparing the SOFA scores with the NDA 
and FNDA intensities, the SOFA scores showed 
negative correlations with the NDA (r = –0.329, P = 
0.001) and FNDA (r = –0.449, P<0.001) (Figure S19) 
intensities. To confirm the abilities of NDA and 
FNDA to predict mortality in sepsis patients, we 
compared the area under the curve (AUC) and cut-off 
values of NDA and FNDA with those of the APACHE 
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II and SOFA scores. The AUC of NDA was 0.758 (P< 
0.001, 95% CI 0.657-0.858), and the AUC of FNDA was 
0.744 (P< 0.001, 95% CI 0.641-0.846) (Figure 9). The 
cut-off values of NDA and FNDA were 95.6 
(sensitivity 0.772, specificity 0.721) and 57.6 
(sensitivity 0.772, specificity 0.738), respectively 
(Table S3). By contrast, the AUCs of the APACHE II 
and SOFA scores were 0.658 and 0.724, respectively 
(Table S3), and the cut-off values of the APACHE II 
and SOFA scores were 28.5 (sensitivity 0.721, 
specificity 0.639) and 12.5 (sensitivity 0.754, specificity 
0.611), respectively (Table S3). The AUC, sensitivity 
and specificity of NDA and FNDA were superior to 
those of the APACHE II and SOFA scores, indicating 
that analysing the fluorescence intensities of NDA 
and FNDA had a higher diagnostic power for 
predicting the mortality rate in sepsis patients than 
analysing the APACHE II and SOFA scores. 
Conclusion 
In summary, we successfully synthesized two 
NDA derivatives containing an electron-donating 
group and an electron-withdrawing group. We found 
that the newly developed probe MNDA, which 
incorporates an electron-donating group, is capable of 
detecting GSH in live cells with two-photon 
microscopy (TPM). All of the NDA derivatives were 
able to detect intracellular GSH in HeLa cells. Among 
the three probes, NDA and FNDA were able to 
identify sepsis and predict mortality in patients with 
sepsis. In addition, in this study, we didn’t quantify 
the GSH levers in human serum due to the potential 
interference of related proteins and its complicated 
environment. Thus, not only GSH, but also related 
proteins may affect the results.[51] We believe these 
results open up a promising direction for further 
medical diagnostic techniques. 
 
 
Figure 8. Fluorescence intensities from NDA and FNDA in the following three groups: healthy controls, 28-d survivors, and 28-d non-survivors. (A) The 
fluorescence intensity of NDA. (B) The fluorescence intensity of FNDA. 
 
Figure 9. ROC curves used to predict mortality in sepsis patients. (A) ROC curves of NDA and FNDA. (B) ROC curves of APACHE II and SOFA scores. (C) The 
AUC, cut-off, sensitivity and specificity values of NDA, FNDA, the APACHE II score and the SOFA score for the prediction of mortality in sepsis patients. 
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Abbreviations 
GSH: glutathione; Cys: cysteine; Hcy: 
homocysteine; TPM: two-photon microscopy; NDA: 
naphthalene-2,3-dicarboxaldehyde; MNDA: 6-metho-
xynaphthalene-2, 3-dicarbaldehyde; FNDA: 6-fluoro-
naphthalene-2,3-dicarbaldehyde; TPEF: two-photon 
excited fluorescence; ICUs: intensive care units; AUC: 
area under the curve; SOFA: sepsis-related organ 
failure assessment; APACHE II: chronic health 
evaluation II.  
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